Medicare Enrolled
Dr. Meghna Kumar-Pelayo, M.D.
Epilepsy Physician · St Petersburg, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kumar-Pelayo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kumar-Pelayo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kumar-Pelayo
Dr. Meghna Kumar-Pelayo is an epilepsy physician in St Petersburg, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Kumar-Pelayo performed 549 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kumar-Pelayo received a total of $8,191 from 69 pharmaceutical and/or device companies across 412 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kumar-Pelayo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 11% volume in FL
$8,191 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗549
Medicare services
Top 11% in FL for epilepsy physician
Not available
Unique patients (not deduplicated)
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
197 | $83 | $304 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
71 | $42 | $143 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
69 | $59 | $220 |
| New patient office visit, complex (60-74 min) | 56 | $143 | $507 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
44 | $63 | $179 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $115 | $387 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $136 | $498 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
17 | $94 | $257 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $112 | $408 |
| EEG monitoring for coma or sleep This procedure measures brain wave activity to monitor patients who are in a coma or asleep. |
13 | $44 | $144 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
11 | $35 | $144 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,191
Total received (2018-2024)
Avg $1,170/year across 7 years
Top 33% in FL for epilepsy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
412
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,662
2023
$2,002
2022
$720
2021
$271
2020
$363
2019
$1,180
2018
$993
Payments by company (2024)
ABBVIE INC.
$450
Alexion Pharmaceuticals, Inc.
$190
UCB, Inc.
$189
MITSUBISHI TANABE PHARMA AMERICA, INC.
$181
Takeda Pharmaceuticals U.S.A., Inc.
$172
Novartis Pharmaceuticals Corporation
$146
PFIZER INC.
$132
CATALYST PHARMACEUTICALS, INC.
$123
ARGENX US, INC.
$89
Eisai Inc.
$88
GE HEALTHCARE
$81
Sumitomo Pharma America, Inc.
$72
Merz Pharmaceuticals, LLC
$71
Lilly USA, LLC
$66
Vanda Pharmaceuticals Inc.
$63
Acorda Therapeutics, Inc
$57
Amgen Inc.
$48
Neurocrine Biosciences, Inc.
$44
Biogen, Inc.
$40
AstraZeneca Pharmaceuticals LP
$39
Celgene Corporation
$38
Genentech USA, Inc.
$38
SK Life Science, Inc.
$35
Alnylam Pharmaceuticals Inc.
$29
Xeris Pharmaceuticals, Inc.
$25
Janssen Pharmaceuticals, Inc
$24
Grifols USA, LLC
$24
TG Therapeutics, Inc.
$23
Neurelis, Inc.
$22
LivaNova USA, Inc.
$20
Lundbeck LLC
$18
Nevro Corp.
$16
Aucta Pharmaceuticals, Inc.
$12
Top 3 companies account for 31.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$924
Alexion Pharmaceuticals, Inc.
$453
UCB, Inc.
$422
Teva Pharmaceuticals USA, Inc.
$403
Novartis Pharmaceuticals Corporation
$368
PFIZER INC.
$309
GE HealthCare
$304
Takeda Pharmaceuticals U.S.A., Inc.
$287
Amgen Inc.
$232
Lilly USA, LLC
$222
Sunovion Pharmaceuticals Inc.
$221
MITSUBISHI TANABE PHARMA AMERICA, INC.
$181
Allergan, Inc.
$174
Eisai Inc.
$173
GE HEALTHCARE
$173
Neurocrine Biosciences, Inc.
$172
GENZYME CORPORATION
$160
SK Life Science, Inc.
$157
Biogen, Inc.
$156
ARGENX US, INC.
$151
Acorda Therapeutics, Inc
$150
CSL Behring
$149
Sumitomo Pharma America, Inc.
$146
CATALYST PHARMACEUTICALS, INC.
$123
Supernus Pharmaceuticals, Inc.
$121
PORTOLA PHARMACEUTICALS, INC.
$114
Chiesi USA, Inc.
$102
AstraZeneca Pharmaceuticals LP
$100
Allergan Inc.
$94
Genentech USA, Inc.
$91
Merz Pharmaceuticals, LLC
$71
Horizon Therapeutics plc
$70
Alnylam Pharmaceuticals Inc.
$67
Bayer HealthCare Pharmaceuticals Inc.
$66
Vanda Pharmaceuticals Inc.
$63
Upsher-Smith Laboratories LLC
$53
AbbVie Inc.
$52
Celgene Corporation
$51
BANNER LIFE SCIENCES, LLC
$48
Greenwich Biosciences, Inc.
$45
Xeris Pharmaceuticals, Inc.
$45
Biohaven Pharmaceutical Holding Company Ltd.
$44
LivaNova USA, Inc.
$44
ACADIA Pharmaceuticals Inc
$43
Jazz Pharmaceuticals Inc.
$43
Lundbeck LLC
$42
Janssen Pharmaceuticals, Inc
$41
Grifols USA, LLC
$40
Biohaven Pharmaceuticals, Inc.
$38
JAZZ PHARMACEUTICALS INC.
$36
Catalyst Pharmaceuticals, Inc.
$32
Mallinckrodt Hospital Products Inc.
$27
Otsuka America Pharmaceutical, Inc.
$26
Bausch Health US, LLC
$24
TG Therapeutics, Inc.
$23
Akcea Therapeutics, Inc.
$22
Neurelis, Inc.
$22
Vertical Pharmaceuticals, LLC
$21
Corium, LLC
$19
Promius Pharma LLC
$17
IDORSIA PHARMACEUTICALS US INC
$16
Nevro Corp.
$16
Zyla Life Sciences
$15
EMD Serono, Inc.
$15
Amneal Pharmaceuticals LLC
$14
Avanir Pharmaceuticals, Inc.
$14
Aucta Pharmaceuticals, Inc.
$12
Medtronic USA, Inc.
$12
Egalet US Inc
$11
Top 3 companies account for 22.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AGAMREE · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Betaseron · Briviact · CARDENE · COMIRNATY · COPAXONE · DUOPA · EMGALITY · EPIDIOLEX · EVUSHELD · Epidiolex · Evrysdi · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GILENYA · Gamunex-C · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · LEMTRADA · Leqembi · MAYZENT · MIGRANAL · Mavenclad · Motpoly XR · NUEDEXTA · NUPLAZID · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · PONVORY · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · RELEXXII · REXULTI · RYTARY · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SYNCHROMED · Senza · Soliris · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XARELTO · XCOPRI · XYREM · Xeomin · Xyrem · ZEPOSIA · Zembrace · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Epilepsy physicians in nearby ZIP areas
1
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
ST ANTHONYS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kumar-Pelayo is a clinical cardiology specialist, with above-average Medicare volume (top 11% in FL), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kumar-Pelayo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kumar-Pelayo performed 197 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kumar-Pelayo receive payments from pharmaceutical companies?
Yes. Dr. Kumar-Pelayo received a total of $8,191 from 69 companies across 412 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kumar-Pelayo's costs compare to other epilepsy physicians in St Petersburg?
Dr. Kumar-Pelayo's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kumar-Pelayo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Epilepsy Physicians in St Petersburg
Browse epilepsy physicians in St Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Epilepsy Physicians in FL
Epilepsy physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Epilepsy Physicians in FL
Which FL epilepsy physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology